Multimorbidity is common in rheumatoid arthritis and progresses more rapidly during and immediately following onset. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. People with rheumatoid arthritis often […]
Category: Rheumatoid arthritis
Temporary interruption of face-to-face consultations has no major impact
A short interruption of in-person rheumatology appointments has no major impact on the disease course of axial spondyloarthritis, rheumatoid arthritis or psoriatic arthritis. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March […]
VTE risk increases with disease activity in RA
There is a strong association between disease activity and the risk of blood clots in people with rheumatoid arthritis INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages […]
No significant difference between advanced therapies for RA
Individualised care should be based on clinical judgement and consideration of patient preferences. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. The goal of treatment is often remission […]
Managing RA with DMARDs
This is the lay version of the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis using synthetic and biologic disease-modifying antirheumatic drugs. The original publication can be downloaded from the EULAR website: www.eular.org. Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic […]
Tapering sequence does not affect costs
Slowly reducing medicines for people in remission can save money INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. When people reach sustained remission (no signs or symptoms of […]
There are still gaps in standards of care of people with rheumatoid arthritis
More work needs to be done to make sure EULAR standards of care are used across Europe INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. In 2008, the […]
People with early RA have signs of cardiovascular changes
Treatments for rheumatoid arthritis might also help to reduce cardiovascular damage INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that can affect a person’s joints, and may cause pain and disability. Rheumatoid arthritis affects people of all ages, and is more common in women than men. People with rheumatoid arthritis have an increased risk of […]
Economic status, location, and healthcare system impact how well treatments work in trials
More consistent reporting of patient characteristics is needed across rheumatology trials. INTRODUCTION Rheumatic diseases affect people’s joints, bones, tendons, ligaments and muscles – and often also other organs. Many of these diseases are autoimmune conditions that cause inflammation in the body. There are more than 200 rheumatic diseases, including rheumatoid arthritis, osteoarthritis, psoriatic arthritis, spondyloarthritis, […]
Managing RA with DMARDs
This is the lay version of the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis using synthetic and biologic disease-modifying antirheumatic drugs. The original publication can be downloaded from the EULAR website: www.eular.org. Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic […]
